Skip to main content
Journal cover image

Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.

Publication ,  Journal Article
Naylor, JC; Hulette, CM; Steffens, DC; Shampine, LJ; Ervin, JF; Payne, VM; Massing, MW; Kilts, JD; Strauss, JL; Calhoun, PS; Calnaido, RP ...
Published in: J Clin Endocrinol Metab
August 2008

OBJECTIVE: It is currently unknown whether cerebrospinal fluid (CSF) neurosteroid levels are related to brain neurosteroid levels in humans. CSF and brain dehydroepiandrosterone (DHEA) levels are elevated in patients with Alzheimer's disease (AD), but it is unclear whether CSF DHEA levels are correlated with brain DHEA levels within the same subject cohort. We therefore determined DHEA and pregnenolone levels in AD patients (n = 25) and cognitively intact control subjects (n = 16) in both CSF and temporal cortex. DESIGN: DHEA and pregnenolone levels were determined by gas chromatography/mass spectrometry preceded by HPLC. Frozen CSF and temporal cortex specimens were provided by the Alzheimer's Disease Research Center at Duke University Medical Center. Data were analyzed by Mann-Whitney U test statistic and Spearman correlational analyses. RESULTS: CSF DHEA levels are positively correlated with temporal cortex DHEA levels (r = 0.59, P < 0.0001) and neuropathological disease stage (Braak and Braak) (r = 0.42, P = 0.007). CSF pregnenolone levels are also positively correlated with temporal cortex pregnenolone levels (r = 0.57, P < 0.0001) and tend to be correlated with neuropathological disease stage (Braak) (r = 0.30, P = 0.06). CSF DHEA levels are elevated (P = 0.032), and pregnenolone levels tend to be elevated (P = 0.10) in patients with AD, compared with cognitively intact control subjects. CONCLUSIONS: These findings indicate that CSF DHEA and pregnenolone levels are correlated with temporal cortex brain levels of these neurosteroids and that CSF DHEA is elevated in AD and related to neuropathological disease stage. Neurosteroids may thus be relevant to the pathophysiology of AD.

Duke Scholars

Published In

J Clin Endocrinol Metab

DOI

ISSN

0021-972X

Publication Date

August 2008

Volume

93

Issue

8

Start / End Page

3173 / 3178

Location

United States

Related Subject Headings

  • Temporal Lobe
  • Pregnenolone
  • Humans
  • Endocrinology & Metabolism
  • Dehydroepiandrosterone
  • Alzheimer Disease
  • Aged, 80 and over
  • Aged
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Naylor, J. C., Hulette, C. M., Steffens, D. C., Shampine, L. J., Ervin, J. F., Payne, V. M., … Marx, C. E. (2008). Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab, 93(8), 3173–3178. https://doi.org/10.1210/jc.2007-1229
Naylor, Jennifer C., Christine M. Hulette, David C. Steffens, Lawrence J. Shampine, John F. Ervin, Victoria M. Payne, Mark W. Massing, et al. “Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.J Clin Endocrinol Metab 93, no. 8 (August 2008): 3173–78. https://doi.org/10.1210/jc.2007-1229.
Naylor JC, Hulette CM, Steffens DC, Shampine LJ, Ervin JF, Payne VM, et al. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab. 2008 Aug;93(8):3173–8.
Naylor, Jennifer C., et al. “Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage.J Clin Endocrinol Metab, vol. 93, no. 8, Aug. 2008, pp. 3173–78. Pubmed, doi:10.1210/jc.2007-1229.
Naylor JC, Hulette CM, Steffens DC, Shampine LJ, Ervin JF, Payne VM, Massing MW, Kilts JD, Strauss JL, Calhoun PS, Calnaido RP, Blazer DG, Lieberman JA, Madison RD, Marx CE. Cerebrospinal fluid dehydroepiandrosterone levels are correlated with brain dehydroepiandrosterone levels, elevated in Alzheimer's disease, and related to neuropathological disease stage. J Clin Endocrinol Metab. 2008 Aug;93(8):3173–3178.
Journal cover image

Published In

J Clin Endocrinol Metab

DOI

ISSN

0021-972X

Publication Date

August 2008

Volume

93

Issue

8

Start / End Page

3173 / 3178

Location

United States

Related Subject Headings

  • Temporal Lobe
  • Pregnenolone
  • Humans
  • Endocrinology & Metabolism
  • Dehydroepiandrosterone
  • Alzheimer Disease
  • Aged, 80 and over
  • Aged
  • 3202 Clinical sciences
  • 1114 Paediatrics and Reproductive Medicine